221 related articles for article (PubMed ID: 33348862)
1. Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics.
Dörnen J; Myklebost O; Dittmar T
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348862
[TBL] [Abstract][Full Text] [Related]
2. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.
Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T
BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties.
Fahlbusch SS; Keil S; Epplen JT; Zänker KS; Dittmar T
BMC Cancer; 2020 May; 20(1):446. PubMed ID: 32430004
[TBL] [Abstract][Full Text] [Related]
4. Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells.
Zhang LN; Kong CF; Zhao D; Cong XL; Wang SS; Ma L; Huang YH
J Cell Physiol; 2019 Apr; 234(4):3570-3582. PubMed ID: 30417342
[TBL] [Abstract][Full Text] [Related]
5. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
[TBL] [Abstract][Full Text] [Related]
6. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.
Zhang LN; Zhang DD; Yang L; Gu YX; Zuo QP; Wang HY; Xu J; Liu DX
FEBS J; 2021 Mar; 288(5):1447-1456. PubMed ID: 33070450
[TBL] [Abstract][Full Text] [Related]
7. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
8. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
11. Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.
Melzer C; Ohe JV; Hass R
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172211
[TBL] [Abstract][Full Text] [Related]
12. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
Yin X; Wolford CC; Chang YS; McConoughey SJ; Ramsey SA; Aderem A; Hai T
J Cell Sci; 2010 Oct; 123(Pt 20):3558-65. PubMed ID: 20930144
[TBL] [Abstract][Full Text] [Related]
13. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
Kröger C; Afeyan A; Mraz J; Eaton EN; Reinhardt F; Khodor YL; Thiru P; Bierie B; Ye X; Burge CB; Weinberg RA
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7353-7362. PubMed ID: 30910979
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity.
Rappa G; Mercapide J; Lorico A
Am J Pathol; 2012 Jun; 180(6):2504-15. PubMed ID: 22542847
[TBL] [Abstract][Full Text] [Related]
18. Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC).
Melzer C; von der Ohe J; Hass R
Cell Commun Signal; 2018 Jan; 16(1):2. PubMed ID: 29329589
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
20. Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b.
Xu H; Li W; Luo S; Yuan J; Hao L
Cell Signal; 2019 Oct; 62():109350. PubMed ID: 31254605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
